Health Catalyst, Inc. (HCAT)

Market Cap	576.47M
Revenue (ttm)	284.60M
Net Income (ttm)	-147.32M
Shares Out	56.96M
EPS (ttm)	-2.68
PE Ratio	n/a
Forward PE	186.01
Dividend	n/a
Ex-Dividend Date	n/a

Volume	916,574
Open	9.72
Previous Close	9.66
Day's Range	9.66 - 10.14
52-Week Range	6.40 - 15.87
Beta	1.28
Analysts	Buy
Price Target	14.88 (+47.04%)
Earnings Date	Nov 7, 2023

About HCAT

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company offers data operating system data platform for analytics, and application development and interoperability that provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications designed to analyze the problems faced across clinica...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Jul 25, 2019
• Employees: 1,200
• Stock Exchange: NASDAQ
• Ticker Symbol: HCAT

Financial Performance

In 2022, HCAT's revenue was $276.24 million, an increase of 14.18% compared to the previous year's $241.93 million. Losses were -$137.40 million, -10.32% less than in 2021.

Analyst Forecast

According to 10 analysts, the average rating for HCAT stock is "Buy." The 12-month stock price forecast is $14.88, which is an increase of 47.04% from the latest price.

Price Target

$14.88

(47.04% upside)

Analyst Consensus: Buy